<?xml version="1.0" encoding="UTF-8"?>
<p>Local or systemic steroids can significantly reduce the mass and control the lesions, lymphadenopathy and nephrotic syndrome (
 <xref rid="B17" ref-type="bibr">17</xref>). Oral prednisolone has a high degree of individualization, and administered in different doses, durations and gradual reduction schemes according to the size of the primary or recurrent lesions (
 <xref rid="B18" ref-type="bibr">18</xref>â€“
 <xref rid="B20" ref-type="bibr">20</xref>). Even so, the mass also has recurrence after glucocorticoid reduction (about 45.8%) (
 <xref rid="B21" ref-type="bibr">21</xref>).
</p>
